Trial ID or NCT#



not recruiting iconNOT RECRUITING


The purpose of this study is to determine whether the use of dexmedetomidine, a selective α2-adrenergic receptor agonist with sedative, analgesic, and antinociceptive properties, would be associated with a lower incidence of delirium when compared to propofol and midazolam. We hypothesize that sedation with dexmedetomidine following cardiac surgery with CPB will be associated with a lower incidence of postoperative delirium.

Official Title

ICU Delirium: Can Dexmedetomidine Reduce Its Incidence?

Eligibility Criteria

Ages Eligible for Study: 18 Years to 89 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes


Jose R. Maldonado, MD, FAPM
Jose R. Maldonado, MD, FAPM
Psychiatrist, Transplant psychiatrist, Neuropsychiatrist
John and Terry Levin Family Professor of Medicine and Professor, by courtesy, of Emergency Medicine and of Medicine

Contact us to find out if this trial is right for you.